4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-23-058973
Options or other derivatives
- President and Head of R&D acquired 334,005 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Nagendran Sukumar President and Head of R&D | 2023-12-14 | Grant or award · Employee Stock Option (right to buy) | +334,005 | 334,005 | D | ||
Loading xslF345X05/doc4.xml…